Select Page

CAMBRIDGE, Mass. and┬áROTTERDAM, Netherlands and┬áSUZHOU, SHANGHAI, China, July 31, 2020 /PRNewswire/ — Harbour BioMed (HBM), a global clinical stage biopharmaceutical company and Viva Biotech (